Literature DB >> 9181842

[New blindness incidents in Württemberg-Hohenzollern].

H G Krumpaszky1, A Haas, V Klauss, H K Selbmann.   

Abstract

UNLABELLED: Blindness causes human suffering and high social costs. Preventive measures are necessary. Virtually all blind people are registered with the social services. Data from these institutions may help in (long-term) planning for blindness prevention.
MATERIAL AND METHODS: The present investigation analysed data from the social services of the region Württemberg-Hohenzollern. The files contained information on ocular status, year of birth, district, and sex of newly blind subjects of the year 1994.
RESULTS: Two thirds (66.8%) of newly blind subjects are women. About half (47.8%) of all subjects are over 80 years of age. The most frequent causes of blindness are: macular degeneration, 33.7%; diabetic retinopathy, 17.3%; glaucoma, 13.8%; and high myopia, 6.6%.
CONCLUSIONS: Blindness is increasingly a problem of high age. Diabetic retinopathy and glaucoma are still major causes of blindness. For these diseases blindness prevention is conceivable. Thus co-ordinated blindness prevention activities should focus on diabetic retinopathy and glaucoma.

Entities:  

Mesh:

Year:  1997        PMID: 9181842     DOI: 10.1007/s003470050108

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  4 in total

1.  [Spectrum of ophthalmologic and social rehabilitation at the Tübinger Low-Vision Clinic : a retrospective analysis for 1999-2005].

Authors:  N X Nguyen; M Weismann; S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

Review 2.  [Age-related macular degeneration: a socioeconomic time bomb in our aging society].

Authors:  W F Schrader
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

3.  [Problems for ophthalmologists in the certification of blindness ].

Authors:  M Gräf; M Jomaa
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

4.  [Photodynamic therapy for severe myopia].

Authors:  I Krebs; S Binder; U Stolba; A Abri
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.